Recall Z-1194-2019

Roche Diagnostics Corporation · initiated March 18, 2019

Class II Terminated

Class II – products that might cause a temporary health problem or pose a slight threat of a serious nature

Product

Albumin BCP Product Usage: ALBP is an in vitro test used for the quantitative determination of albumin in human serum and plasma on Roche/Hitachi cobas c systems.

Codes / lots: Catalog Number 05975573190 Lot Number 35651401

Reason for recall

The reagent lot is exhibiting calibration failures, QC imprecision, and elevated QC recovery due to elevated pH level causing higher absorbance values.

FDA-determined cause: Process control

Action taken

Urgent Medical Device Correction notification letters dated 3/18/19 were sent to customers. The letter identified the affected product, problem and actions to be taken. The letter instructed customers to: Stop using and discard all Albumin BCP reagent cassettes from lot number 35651401 (catalog number 05975573190) remaining in your inventory according to your local guidelines. Actions Required " Complete all sections of the enclosed fax form and fax it to 1-833-254-2600 or email it to Roche10060@stericycle.com even if you are not requesting product replacement. " Discard remaining affected product in your inventory according to local guidelines. " File this Urgent Medical Device Correction (UMDC) for future reference.

Details

Recall number
Z-1194-2019
Initiated
March 18, 2019
Terminated
August 28, 2020
Product code
CJW – Bromcresol Purple Dye-Binding, Albumin
Quantity
774
Distribution
US Nationwide distribution in the states of: GA, IL, KY, MI, and TX.
Recalling firm
Roche Diagnostics Corporation, Indianapolis, IN

Official FDA recall record